Renovate Biosciences

What Renovate Biosciences does

Renovate Biosciences is a Delaware-incorporated, Maryland-based animal biotechnology company founded in 2016 that develops custom genetic engineering tools and research models for the biotechnology research market. Its commercial offering spans two related layers. The first is a portfolio of therapeutic platform categories — gene therapy, immunotherapy, cell therapy, bioengineering, and regenerative medicine/xenotransplantation (including exogenous organ generation such as liver) — positioned as the company's R&D and capability surface. The second is a research-model product line built around swine genetics, including in-house swine models and precision pig models designed specifically for cancer research, biomarker discovery, and pre-clinical evaluation across surgical, radiological, and immunological modalities.

Underlying the offering is what the company describes as more than five decades of combined genetic engineering expertise applied to a wide range of swine genetics, enabling bespoke model generation for client research programs. The business model is services- and license-driven: Renovate Biosciences sells custom genetic engineering models under a one-time license structure and provides professional biotechnology research services (gene therapy, immunotherapy, cell therapy, bioengineering) to research institutions, pharmaceutical companies, and biotech firms. Pricing is quote-based and not publicly disclosed; customer acquisition runs through the company website, email outreach, and free online consultations offered via WhatsApp and email.

The go-to-market is direct-to-customer with global aspiration but a North American operating footprint. The company is privately held, has no public financials, no disclosed funding rounds, and reports minimal leadership data beyond CEO Robert Etches. Limited public verification — no disclosed patents, certifications, awards, or named customers — constrains visibility into commercialization traction.

Name

Renovate Biosciences

Legal name

Renovate Biosciences

Website

https://renovatebiosciences.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Short description

Renovate Biosciences is a Maryland-based animal biotechnology company that designs custom genetic engineering models — particularly precision pig models for cancer research — and offers gene therapy, immunotherapy, cell therapy, bioengineering, and regenerative medicine platforms to research institutions and biotech firms.

Ownership category

akta.pro rank

Product category

Animal Biotechnology Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Cell & Gene Therapy for Veterinary Regeneration (HLAMANAD)

akta.pro secondary industries

Veterinary Regenerative Medicine Manufacturing (GMP/CDMO, Cell Processing) (HLAMANAI), Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development) (HLAAAIAD), Clinical Research, Trials & Translational Services (Veterinary Regenerative) (HLAMANAL)

Keywords

• Animal biotechnology services
• Custom genetic engineering models
• Precision pig models
• Cancer research models
• Xenotransplantation research

Headquarters

HQ city

Reisterstown

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales

Revenue model

1. Custom Genetic Engineering Models: Sale of custom in-house swine models and genetic engineering services for biotechnology research needs.
2. Biotechnology Research Services: Providing expertise and services in gene therapy, immunotherapy, cell therapy, and bioengineering solutions for research institutions and biotech companies.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Renovate Biosciences is an animal biotechnology company that develops and delivers custom genetic engineered models, with a particular focus on swine genetics and precision pig models for cancer research. The company leverages more than five decades of combined genetic engineering expertise to generate bespoke animal models and offer services spanning gene therapy, immunotherapy, cell therapy, bioengineering, and regenerative medicine/xenotransplantation for research institutions and biotech firms.

Product overview

Renovate Biosciences is a biotechnology company offering a comprehensive portfolio of advanced therapeutic and research platforms. The company provides gene therapy, immunotherapy, cell therapy, bioengineering, and regenerative medicine/xenotransplantation as core technology platforms, complemented by specialized research model products including precision pig models for cancer research, custom genetic engineered models, and swine genetics. The therapeutic platforms focus on addressing genetic diseases, cancer, and autoimmune disorders, while the research models support biomarker discovery and drug development through genetically engineered animal models.

Differentiator

Problem solved

Functional benefit

Products and services

• Custom Genetic Engineered Models

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

One partnership is on record.

• TruScreenminorChannel Partner/ Reseller/ Distributor · 8 May 2025Renovate Biologicals (noted as a related entity to Renovaro Biosciences) reentered the Indian market through a distribution partnership with TruScreen to promote cervical cancer screening technology. This appears to be a separate commercial distribution arrangement for medical screening products.

Scale indicators2 records

Recent moves3 records

Expansion highlights3 records

Emerging players

• eGenesis: Gene-editing company developing human-compatible pig organs for xenotransplantation. Comparable through its xenotransplantation focus and use of advanced genetic engineering in swine.
• RenovaCare: Regenerative medicine company developing cell-based therapies and spray-on skin technologies. Comparable as a small regenerative medicine/biologics company with related cell therapy focus.
• Revivicor (United Therapeutics): Subsidiary developing genetically engineered pig organs for human transplantation. Comparable on the xenotransplantation platform and precision pig genetic engineering.

Broad incumbents

• Taconic Biosciences: Major provider of genetically engineered rodent models and related research services. Comparable as an established animal model supplier to biomedical research customers.
• Charles River Laboratories: Global CRO providing research animal models, preclinical services, and biopharmaceutical support. A broad incumbent comparable across custom models and research services.
• Inotiv: A larger contract research organization offering animal models, preclinical research services, and research products. Comparable as a broad incumbent in the research animal model and preclinical services market.

Direct peers

• Cyagen Biosciences: Provides custom animal models (rodent and other species) and cell/gene therapy research services. Comparable on custom model generation and gene/cell therapy service offerings.
• Hera BioLabs: Specializes in genetically engineered rat and mouse models, including humanized liver models for research. Comparable as a custom genetic engineered animal model provider serving therapeutic development.
• Exemplar Genetics: A U.S.-based provider of custom genetically engineered swine models for biomedical research, including oncology and gene therapy applications. Closely comparable to Renovate Biosciences' precision pig model and custom genetic engineering offering.

Others

• Transgenic & Xenotransplantation Research Group (academic entities): Academic and consortium groups (e.g., NIH, MGH xenotransplant programs) that develop custom swine models for regenerative medicine research. Comparable as ecosystem participants influencing demand for Renovate's custom model offerings.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/renovate-biosciences

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Renovate Biosciences